World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00324753
Date of registration: 09/05/2006
Primary sponsor: Department of Veterans Affairs
Public title: Quality Improvement of Patient-Provider Communication For Colorectal Cancer Screening
Scientific title: Improving Patient-Provider Communication For Colorectal Cancer Screening
Date of first enrolment: April 2007
Target sample size: 450
Recruitment status: Suspended
URL:  http://clinicaltrials.gov/show/NCT00324753
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Prevention  
Countries of recruitment
United States
Contacts
Name:   Bruce S. Ling, MD MPH
Address: 
Telephone:
Email:
Affiliation:  Center for Health Equity Research and Promotion
Key inclusion & exclusion criteria

Inclusion Criteria:

Provider Eligibility. Primary care providers (MD, CRNP, or PA) at the study sites who see
patients in the primary care setting at least 1 day per week and had no involvement in the
design of the study are eligible for enrollment in the study.

Patient Eligibility. Primary care patients who are not "up-to-date" with colorectal cancer
screening are the targeted population for study enrollment. Up-to-date with colorectal
cancer screening is defined as having completed one of the following: (1) fecal occult
blood testing within the past year; (2) sigmoidoscopy within the past 5 years; (3)
colonoscopy within the past 10 years; or (4) barium enema within the past 5 years. Other
patient eligibility criteria are: (1) PCP enrolled in the study; (2) clinic visit
scheduled with the enrolled PCP during the recruitment period; (3) age 50-74 years; (4)
English speaking; (5) no prior history of colorectal cancer or adenomatous polyps; and (6)
no prior history of inflammatory bowel disease.

Exclusion Criteria:

Patients who are deemed clinically not appropriate for colorectal cancer screening due to
severe comorbidity and/or limited life expectancy as determined by the patient's primary
care provider will be excluded from the study.



Age minimum: 50 Years
Age maximum: 74 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Colorectal Cancer
Intervention(s)
Behavioral: Communication
Primary Outcome(s)
(1) completion of colorectal cancer screening tests; (2) quality of communication; and (3) communication content [Time Frame: No]
Secondary Outcome(s)
(1) patient perception of colorectal cancer screening discussions; and (2) usefulness of the intervention [Time Frame: No]
Secondary ID(s)
IIR 03-252
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history